DICER1 and neoplasm: In this era of precision medicine, not only can we judge the degree of drug resistance through the level of phosphorylated Dicer in tumor tissues of different patients, but we can also provide appropriate adjuvant therapy based on the phosphorylation of Dicer at different sites.